Transfer and loss of allergen‐specific responses via stem cell transplantation: A prospective observational study
- 17 March 2020
- Vol. 75 (9), 2243-2253
- https://doi.org/10.1111/all.14278
Abstract
Background Currently, no estimates can be made on the impact of hematopoietic stem cell transplantation on allergy transfer or cure of the disease. By using component‐resolved diagnosis we prospectively investigated fifty donor‐recipient pairs undergoing allogeneic stem cell transplantation. This allowed calculating the rate of transfer or maintenance of allergen‐specific responses in the context of stem cell transplantation. Methods Allergen‐specific IgE and IgG to 156 allergens was measured pre‐transplantation in 50 donors and recipients and at six, 12 and 24 months in recipients post‐transplantation by allergen microarray. Based on a mixed effects model, we determined risks of transfer of allergen‐specific IgE or IgG responses 24 months post‐transplantation. Results After undergoing stem cell transplantation, 94% of allergen‐specific IgE responses were lost. Two years post‐transplantation, recipients’ allergen‐specific IgE was significantly linked to the pre‐transplantation donor or recipient status. The estimated risk to transfer and maintain individual IgE responses to allergens by stem cell transplantation was 1.7% and 2.3% respectively. Allergen‐specific IgG, which served as a surrogate marker of maintaining protective IgG responses, was highly associated with the donor’s (31.6%) or the recipient’s (28%) pre‐transplantation response. Conclusion Hematopoietic stem cell transplantation profoundly reduces allergen‐specific IgE responses but also comes with a considerable risk to transfer allergen‐specific immune responses. These findings facilitate clinical decision making regarding allergic diseases in the context of hematopoietic stem cell transplantation. In addition, it provides prospective data to estimate the risk of transmitting allergen‐specific responses via hematopoietic stem cell transplantation.Keywords
Funding Information
- Government Council on Grants, Russian Federation (14.W03.31.0024)
- Austrian Science Fund (SFB F4605, SFB F4615, W 1248‐B13 MCCA)
- Hospital for Sick Children (Start‐up funds)
This publication has 47 references indexed in Scilit:
- Atopic sensitization in the first year of lifeJournal of Allergy and Clinical Immunology, 2013
- New developments in transplant-acquired allergiesWorld Journal of Transplantation, 2013
- Hematopoietic Stem Cell Transplantation for Systemic Lupus ErythematosusClinical and Developmental Immunology, 2012
- Cytomegalovirus in Hematopoietic Stem Cell Transplant RecipientsHematology/Oncology Clinics of North America, 2011
- Immunoglobulin E-Mediated Allergies in Lung-Transplanted AdultsTransplantation, 2007
- Hematopoietic stem cell transplantation in autoimmune diseases: Is the glass half full or half empty?Arthritis & Rheumatism, 2006
- Immunosuppressive Therapy Does Not Prevent the Occurrence of Immunoglobulin E–Mediated Allergies in Children and Adolescents With Organ TransplantsPublished by American Academy of Pediatrics (AAP) ,2006
- Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidenceBone Marrow Transplantation, 2006
- Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation for Autoimmune Disease: Position Statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute–Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005Transplantation and Cellular Therapy, 2005
- Transfer of Allergen-Specific IgE-Mediated Hypersensitivity with Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1988